Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.58
Bid: 18.40
Ask: 18.60
Change: -0.27 (-1.43%)
Spread: 0.20 (1.087%)
Open: 18.48
High: 18.58
Low: 18.40
Prev. Close: 18.85
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

14 Aug 2023 15:58

RNS Number : 2701J
Nanoco Group PLC
14 August 2023
 

14 August 2023 NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

General Meeting - Voting Results

 

All resolutions proposed by the Requisitionists emphatically rejected

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, is pleased to announce that all resolutions proposed by the Requisitionists at its GM held today were rejected.

 

Votes For

Votes Against

Votes Withheld

Votes

% of total votes cast

% of total voting rights excluding treasury shares

Votes

% of total votes cast

% of total voting rights excluding treasury shares

Votes

% of total voting rights excluding treasury shares

Ordinary Resolution 1

21,042,276

11.9%

6.5%

154,618,459

87.8%

47.7%

468,820

0.3%

Ordinary Resolution 2

31,896,310

18.1%

9.8%

143,773,518

81.6%

44.3%

459,727

0.3%

Ordinary Resolution 3

29,532,600

16.7%

9.1%

146,130,228

83.0%

45.0%

466,727

0.3%

Ordinary Resolution 4

28,528,164

16.2%

8.8%

147,254,957

83.6%

45.4%

346,434

0.2%

Ordinary Resolution 5

31,955,122

18.1%

9.8%

142,250,664

80.8%

43.8%

1,923,769

1.1%

Ordinary Resolution 6

20,974,587

11.9%

6.5%

152,853,810

86.8%

47.1%

2,301,158

1.3%

Ordinary Resolution 7

30,265,193

17.2%

9.3%

145,556,564

82.6%

44.9%

307,798

0.2%

Ordinary Resolution 8

29,519,474

16.8%

9.1%

146,015,018

82.9%

45.0%

595,063

0.3%

Ordinary Resolution 9

18,217,238

10.4%

5.6%

156,967,305

89.1%

48.4%

945,012

0.5%

Ordinary Resolution 10

30,578,152

17.4%

9.4%

145,012,921

82.3%

44.7%

538,482

0.3%

Ordinary Resolution 11

18,787,391

10.7%

5.8%

156,900,972

89.1%

48.4%

442,192

0.2%

Ordinary Resolution 12

31,857,429

18.1%

9.8%

143,442,677

81.4%

44.2%

829,449

0.5%

Christopher Richards, Non-Executive Chairman of Nanoco, said

"I would like to thank shareholders for their overwhelming support for the Board in rejecting all of the Requisitionists' resolutions by such strong margins.

"As a Board, we are always open to scrutiny and critique. We recognise that the Requisitionists' actions and unfounded allegations have caused damage to perceptions of Nanoco and its value. The actions of the Requisitionists have been value destructive for shareholders in that they have required a significant amount of management time, time which should have been spent running the business and generating value for shareholders.

"The Board has always striven to act in the best interests of all shareholders and will continue to do so. Going forward we will respond to shareholder feedback by further improving our communications, adding new electronics sector experience to the Board, while delivering increases in shareholder value.

"The business is in a better position than it's ever been. The organic business is at an exciting inflection point, with funding underpinned by the litigation proceeds. We are actively pursuing further licencing activity, with our position strengthened by the validation of our IP in the Samsung litigation process. We have also committed to returning up to £40m of the net litigation proceeds to Shareholders in February 2024.

"We thank shareholders for their confidence in the Group's Board and strategy and look forward to updating you later in the year."

Full details of each resolution were set out in the Notice of General Meeting which is available on the Company's website at www.nanocotechnologies.com. In accordance with Listing Rule 9.6.2, copies of all the resolutions passed as special business at the Annual General Meeting have been submitted to the National Storage Mechanism and will shortly be available for inspection at National Storage Mechanism | FCA

i) The issued share capital of Nanoco Group PLC on 31 July 2023 was 324,430,950 ordinary shares. Excluding treasury shares, there were 324,418,728 ordinary shares with voting rights.

ii) A "vote withheld" is not a vote in law and is not counted in the calculation of the percentages of the votes cast "For" and "Against" a resolution.

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFESTSISLIV
Date   Source Headline
16th Jul 20214:41 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSNon-dilutive loan note subscription
5th Jul 20217:30 amRNSDevelopment Agreement
28th Jun 20217:00 amRNSLitigation update and non-dilutive debt facility
10th Jun 202111:33 amRNSBlocklisting Six-Monthly Return
24th May 202112:20 pmRNSHolding(s) in Company
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.